| Bioactivity | LEI-101 free base is a selective and orally bioavailable CB2 receptor agonist with the potential to inhibit diseases associated with inflammation and/or oxidative stress. LEI-101 free base has a binding potency to CB2 receptors that is approximately 100 times higher than that to CB1 receptors. Its pEC50 value on CB2 receptors is 8, while its pKi value on hERG is less than 4. LEI-101 may have an inhibitory effect on conditions such as kidney disease[1]. |
| CAS | 1228660-00-1 |
| Formula | C23H25FN4O4S |
| Molar Mass | 472.53 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity |
LEI-101 free base
CAS: 1228660-00-1 F: C23H25FN4O4S W: 472.53
LEI-101 free base is a selective and orally bioavailable CB2 receptor agonist with the potential to inhibit diseases ass
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.